Skip to main content
Top
Published in: BMC Neurology 1/2022

Open Access 01-12-2022 | Amyotrophic Lateral Sclerosis | Research

Covid-19 threat and coping: application of protection motivation theory to the pandemic experiences of people affected by amyotrophic lateral sclerosis

Authors: Shelagh K. Genuis, Westerly Luth, Tania Bubela, Wendy S. Johnston

Published in: BMC Neurology | Issue 1/2022

Login to get access

Abstract

Background

People with amyotrophic lateral sclerosis (ALS) are at high risk for severe outcomes from Covid-19 infection. Researchers exploring ALS and Covid-19 have focused primarily on system response and adaptation. Using Protection Motivation Theory, we investigated how people with ALS and family caregivers appraised and responded to Covid-19 threat, the ‘costs’ associated with pandemic response, and how health professionals and systems can better support people affected by ALS who are facing public health emergencies.

Methods

Data were drawn from the ‘ALS Talk Project,’ an asynchronous, moderated focus group study. Participants were recruited from regions across Canada. Seven groups met online over 14 weeks between January and July 2020. Fifty-three participants contributed to Covid-19 discussions. Data were qualitatively analyzed using directed content analysis and the constant-comparative approach.

Results

Participants learned about the Covid-19 pandemic from the media. They rapidly assessed their vulnerability and responded to Covid-19 threat by following recommendations from health authorities, information monitoring, and preparing for worst-case scenarios. Adopting protective behaviors had substantial response costs, including adaptations for medical care and home support workers, threatened access to advance care, and increased caregiver burden. Participants expressed need for ALS-specific, pandemic information from trusted health professionals and/or ALS health charities. Telemedicine introduced both conveniences and costs. Prior experience with ALS provided tools for coping with Covid-19. Threat and coping appraisal was a dynamic process involving ongoing vigilance and adaptation. Findings draw attention to the lack of emergency preparedness among participants and within health systems.

Conclusions

Clinicians should engage ALS patients and families in ongoing discussions about pandemic coping, strategies to mitigate response costs, care pathways in the event of Covid-19 infection, and changing information about Covid-19 variants and vaccines. Healthcare systems should incorporate flexible approaches for medical care, leveraging the benefits of telemedicine and facilitating in-person interaction as needed and where possible. Research is needed to identify strategies to mitigate response costs and to further explore the interaction between prior experience and coping. Further study is also needed to determine how communication about emergency preparedness might be effectively incorporated into clinical care for those with ALS and other medically vulnerable populations.
Literature
1.
go back to reference Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Bio Medica Atenei Parm. 2020;91:157–60. Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Bio Medica Atenei Parm. 2020;91:157–60.
4.
go back to reference Lee K, Worsnop CZ, Grépin KA, Kamradt-Scott A. Global coordination on cross-border travel and trade measures crucial to COVID-19 response. Lancet. 2020;395:1593–5.PubMedPubMedCentralCrossRef Lee K, Worsnop CZ, Grépin KA, Kamradt-Scott A. Global coordination on cross-border travel and trade measures crucial to COVID-19 response. Lancet. 2020;395:1593–5.PubMedPubMedCentralCrossRef
5.
go back to reference Han E, Tan MMJ, Turk E, Sridhar D, Leung GM, Shibuya K, et al. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. Lancet. 2020;396:1525–34.PubMedPubMedCentralCrossRef Han E, Tan MMJ, Turk E, Sridhar D, Leung GM, Shibuya K, et al. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. Lancet. 2020;396:1525–34.PubMedPubMedCentralCrossRef
7.
go back to reference Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primer. 2017;3:17071.CrossRef Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primer. 2017;3:17071.CrossRef
8.
go back to reference Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler Off Publ World Fed Neurol Res Group Mot Neuron Dis. 2009;10:310–23. Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler Off Publ World Fed Neurol Res Group Mot Neuron Dis. 2009;10:310–23.
9.
12.
go back to reference Digala LP, Prasanna S, Rao P, Govindarajan R, Qureshi AI. Impact of COVID- 19 Infection Among Hospitalized Amyotrophic Lateral Sclerosis Patients. J Clin Neuromuscul Dis. 2021;22:180–1.PubMedPubMedCentralCrossRef Digala LP, Prasanna S, Rao P, Govindarajan R, Qureshi AI. Impact of COVID- 19 Infection Among Hospitalized Amyotrophic Lateral Sclerosis Patients. J Clin Neuromuscul Dis. 2021;22:180–1.PubMedPubMedCentralCrossRef
13.
go back to reference Andrews JA, Berry JD, Baloh RH, Carberry N, Cudkowicz ME, Dedi B, et al. Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunities. Muscle Nerve. 2020;62:182–6.PubMedCrossRef Andrews JA, Berry JD, Baloh RH, Carberry N, Cudkowicz ME, Dedi B, et al. Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunities. Muscle Nerve. 2020;62:182–6.PubMedCrossRef
15.
go back to reference Norris SP, Likanje M-FN, Andrews JA. Amyotrophic lateral sclerosis: update on clinical management. [Review]. Curr Opin Neurol. 2020;33:641–8.PubMedCrossRef Norris SP, Likanje M-FN, Andrews JA. Amyotrophic lateral sclerosis: update on clinical management. [Review]. Curr Opin Neurol. 2020;33:641–8.PubMedCrossRef
16.
go back to reference Esselin F, Cruz EDL, Pageot N, Juntas-Moralès R, Alphandéry S, Camu W. Increased worsening of amyotrophic lateral sclerosis patients during Covid-19-related lockdown in France. Amyotroph Lateral Scler Front Degener. 2021;0:1–3. Esselin F, Cruz EDL, Pageot N, Juntas-Moralès R, Alphandéry S, Camu W. Increased worsening of amyotrophic lateral sclerosis patients during Covid-19-related lockdown in France. Amyotroph Lateral Scler Front Degener. 2021;0:1–3.
18.
go back to reference Capozzo R, Zoccolella S, Musio M, Barone R, Accogli M, Logroscino G. Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy. Amyotroph Lateral Scler Front Degener. 2020;21:542–8.CrossRef Capozzo R, Zoccolella S, Musio M, Barone R, Accogli M, Logroscino G. Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy. Amyotroph Lateral Scler Front Degener. 2020;21:542–8.CrossRef
19.
go back to reference De Marchi F, Cantello R, Ambrosini S, Mazzini L, Sarnelli MF, De Marchi I, et al. Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19. Neurol Sci. 2020;41:1365–7.PubMedCrossRef De Marchi F, Cantello R, Ambrosini S, Mazzini L, Sarnelli MF, De Marchi I, et al. Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19. Neurol Sci. 2020;41:1365–7.PubMedCrossRef
21.
go back to reference Pinto S, Quintarelli S, Silani V. New technologies and Amyotrophic Lateral Sclerosis – Which step forward rushed by the COVID-19 pandemic? J Neurol Sci. 2020;418:117081.PubMedPubMedCentralCrossRef Pinto S, Quintarelli S, Silani V. New technologies and Amyotrophic Lateral Sclerosis – Which step forward rushed by the COVID-19 pandemic? J Neurol Sci. 2020;418:117081.PubMedPubMedCentralCrossRef
22.
go back to reference Vasta R, Moglia C, D’Ovidio F, Pede FD, Mattei FD, Cabras S, et al. Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience. Amyotroph Lateral Scler Front Degener. 2020;0:1–4. Vasta R, Moglia C, D’Ovidio F, Pede FD, Mattei FD, Cabras S, et al. Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience. Amyotroph Lateral Scler Front Degener. 2020;0:1–4.
23.
go back to reference Beaulieu D, Berry JD, Paganoni S, Glass JD, Fournier C, Cuerdo J, et al. Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemic. Amyotroph Lateral Scler Front Degener. 2021;22:22–32.CrossRef Beaulieu D, Berry JD, Paganoni S, Glass JD, Fournier C, Cuerdo J, et al. Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemic. Amyotroph Lateral Scler Front Degener. 2021;22:22–32.CrossRef
24.
go back to reference Govindarajan R, Berry JD, Paganoni S, Pulley MT, Simmons Z. Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials. Muscle Nerve. 2020;62:321–6.PubMedCrossRef Govindarajan R, Berry JD, Paganoni S, Pulley MT, Simmons Z. Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials. Muscle Nerve. 2020;62:321–6.PubMedCrossRef
25.
go back to reference Manera U, Cabras S, Daviddi M, Vasta R, Torrieri MC, Palumbo F, et al. Validation of the Italian version of self-administered ALSFRS-R scale. Amyotroph Lateral Scler Front Degener. 2020;0:1–3. Manera U, Cabras S, Daviddi M, Vasta R, Torrieri MC, Palumbo F, et al. Validation of the Italian version of self-administered ALSFRS-R scale. Amyotroph Lateral Scler Front Degener. 2020;0:1–3.
26.
go back to reference Edgar S, Abdul-Aziz NA, Loh EC, Capelle D, Goh K-J, Latif LA, et al. A survey on patients’ disease perception and the impact of the COVID-19 pandemic on persons living with amyotrophic lateral sclerosis in Malaysia. Neurodegener Dis Manag. 2021. https://doi.org/10.2217/nmt-2021-0004. Edgar S, Abdul-Aziz NA, Loh EC, Capelle D, Goh K-J, Latif LA, et al. A survey on patients’ disease perception and the impact of the COVID-19 pandemic on persons living with amyotrophic lateral sclerosis in Malaysia. Neurodegener Dis Manag. 2021. https://​doi.​org/​10.​2217/​nmt-2021-0004.
27.
go back to reference Yanagihashi M, Sugisawa T, Fuchimoto M, Saotome Y, Onozawa K, Matsumoto Y, et al. Contradictory Responses to the COVID-19 Pandemic in Amyotrophic Lateral Sclerosis Patients and Their Families and Caregivers in Japan. Intern Med. 2021;60:1519–24.PubMedPubMedCentralCrossRef Yanagihashi M, Sugisawa T, Fuchimoto M, Saotome Y, Onozawa K, Matsumoto Y, et al. Contradictory Responses to the COVID-19 Pandemic in Amyotrophic Lateral Sclerosis Patients and Their Families and Caregivers in Japan. Intern Med. 2021;60:1519–24.PubMedPubMedCentralCrossRef
28.
go back to reference Weston D, Ip A, Amlôt R. Examining the application of behaviour change theories in the context of infectious disease outbreaks and emergency response: a review of reviews. BMC Public Health. 2020;20:1483.PubMedPubMedCentralCrossRef Weston D, Ip A, Amlôt R. Examining the application of behaviour change theories in the context of infectious disease outbreaks and emergency response: a review of reviews. BMC Public Health. 2020;20:1483.PubMedPubMedCentralCrossRef
29.
go back to reference Floyd DL, Prentice-Dunn S, Rogers RW. A Meta-Analysis of Research on Protection Motivation Theory. J Appl Soc Psychol. 2000;30:407–29.CrossRef Floyd DL, Prentice-Dunn S, Rogers RW. A Meta-Analysis of Research on Protection Motivation Theory. J Appl Soc Psychol. 2000;30:407–29.CrossRef
30.
go back to reference Prentice-Dunn S, Rogers RW. Protection Motivation Theory and preventive health: beyond the Health Belief Model. Health Educ Res. 1986;1:153–61.CrossRef Prentice-Dunn S, Rogers RW. Protection Motivation Theory and preventive health: beyond the Health Belief Model. Health Educ Res. 1986;1:153–61.CrossRef
31.
go back to reference Rogers RW. A Protection Motivation Theory of Fear Appeals and Attitude Change. Aust J Psychol. 1975;91:93–114.CrossRef Rogers RW. A Protection Motivation Theory of Fear Appeals and Attitude Change. Aust J Psychol. 1975;91:93–114.CrossRef
32.
go back to reference Adunlin G, Adedoyin ACA, Adedoyin OO, Njoku A, Bolade-Ogunfodun Y, Bolaji B. Using the protection motivation theory to examine the effects of fear arousal on the practice of social distancing during the COVID-19 outbreak in rural areas. J Hum Behav Soc Environ. 2020;0:1–5. Adunlin G, Adedoyin ACA, Adedoyin OO, Njoku A, Bolade-Ogunfodun Y, Bolaji B. Using the protection motivation theory to examine the effects of fear arousal on the practice of social distancing during the COVID-19 outbreak in rural areas. J Hum Behav Soc Environ. 2020;0:1–5.
33.
go back to reference Al-Rasheed M. Protective Behavior against COVID-19 among the Public in Kuwait: An Examination of the Protection Motivation Theory, Trust in Government, and Sociodemographic Factors. Soc Work Public Health. 2020;35:546–56.PubMedCrossRef Al-Rasheed M. Protective Behavior against COVID-19 among the Public in Kuwait: An Examination of the Protection Motivation Theory, Trust in Government, and Sociodemographic Factors. Soc Work Public Health. 2020;35:546–56.PubMedCrossRef
34.
go back to reference Bhati AS, Mohammadi Z, Agarwal M, Kamble Z, Donough-Tan G. Motivating or manipulating: the influence of health-protective behaviour and media engagement on post-COVID-19 travel. Curr Issue Tour. 2021;24:2088–92.CrossRef Bhati AS, Mohammadi Z, Agarwal M, Kamble Z, Donough-Tan G. Motivating or manipulating: the influence of health-protective behaviour and media engagement on post-COVID-19 travel. Curr Issue Tour. 2021;24:2088–92.CrossRef
35.
go back to reference Ezati Rad R, Mohseni S, Kamalzadeh Takhti H, Hassani Azad M, Shahabi N, Aghamolaei T, et al. Application of the protection motivation theory for predicting COVID-19 preventive behaviors in Hormozgan, Iran: a cross-sectional study. BMC Public Health. 2021;21:466.PubMedPubMedCentralCrossRef Ezati Rad R, Mohseni S, Kamalzadeh Takhti H, Hassani Azad M, Shahabi N, Aghamolaei T, et al. Application of the protection motivation theory for predicting COVID-19 preventive behaviors in Hormozgan, Iran: a cross-sectional study. BMC Public Health. 2021;21:466.PubMedPubMedCentralCrossRef
36.
go back to reference Kowalski RM, Black KJ. Protection Motivation and the COVID-19 Virus. Health Commun. 2021;36:15–22.PubMedCrossRef Kowalski RM, Black KJ. Protection Motivation and the COVID-19 Virus. Health Commun. 2021;36:15–22.PubMedCrossRef
37.
go back to reference Wang M, Kunasekaran P, Rasoolimanesh SM. What influences people’s willingness to receive the COVID-19 vaccine for international travel? Curr Issue Tour. 2021;0:1–6. Wang M, Kunasekaran P, Rasoolimanesh SM. What influences people’s willingness to receive the COVID-19 vaccine for international travel? Curr Issue Tour. 2021;0:1–6.
39.
go back to reference Hodgkinson V, Lounsberry J, M’Dahoma S, Russell A, Jewett G, Benstead T, et al. The Canadian Neuromuscular Disease Registry 2010–2019: A Decade of Facilitating Clinical Research Througha Nationwide, Pan-Neuromuscular Disease Registry. J Neuromuscul Dis. 2021;8:53–61.PubMedPubMedCentralCrossRef Hodgkinson V, Lounsberry J, M’Dahoma S, Russell A, Jewett G, Benstead T, et al. The Canadian Neuromuscular Disease Registry 2010–2019: A Decade of Facilitating Clinical Research Througha Nationwide, Pan-Neuromuscular Disease Registry. J Neuromuscul Dis. 2021;8:53–61.PubMedPubMedCentralCrossRef
40.
go back to reference Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Mot Neuron Disord Off Publ World Fed Neurol Res Group Mot Neuron Dis. 2000;1:293–9. Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Mot Neuron Disord Off Publ World Fed Neurol Res Group Mot Neuron Dis. 2000;1:293–9.
41.
go back to reference Abrams K, Gaiser T. Online Focus Groups. In: Fielding N, Lee R, Blank G, editors. The SAGE Handbook of Online Research Methods. London: SAGE Publications, Ltd; 2017. p. 290–306. Abrams K, Gaiser T. Online Focus Groups. In: Fielding N, Lee R, Blank G, editors. The SAGE Handbook of Online Research Methods. London: SAGE Publications, Ltd; 2017. p. 290–306.
42.
go back to reference Gordon AR, Calzo JP, Eiduson R, Sharp K, Silverstein S, Lopez E, et al. Asynchronous Online Focus Groups for Health Research: Case Study and Lessons Learned. Int J Qual Methods. 2021;20:1609406921990489.CrossRef Gordon AR, Calzo JP, Eiduson R, Sharp K, Silverstein S, Lopez E, et al. Asynchronous Online Focus Groups for Health Research: Case Study and Lessons Learned. Int J Qual Methods. 2021;20:1609406921990489.CrossRef
43.
go back to reference Boateng B, Nelson MK. Online Focus Groups with Parents And Adolescents with Heart Transplants: Challenges and Opportunities. Pediatr Nurs. 2016;42:120–54.PubMed Boateng B, Nelson MK. Online Focus Groups with Parents And Adolescents with Heart Transplants: Challenges and Opportunities. Pediatr Nurs. 2016;42:120–54.PubMed
44.
go back to reference Caron J, Light J. “My World Has Expanded Even Though I’m Stuck at Home”: Experiences of Individuals With Amyotrophic Lateral Sclerosis Who Use Augmentative and Alternative Communication and Social Media. Am J Speech Lang Pathol. 2015;24:680–95.PubMedCrossRef Caron J, Light J. “My World Has Expanded Even Though I’m Stuck at Home”: Experiences of Individuals With Amyotrophic Lateral Sclerosis Who Use Augmentative and Alternative Communication and Social Media. Am J Speech Lang Pathol. 2015;24:680–95.PubMedCrossRef
45.
go back to reference Skelton K, Evans R, LaChenaye J, Amsbary J, Wingate M, Talbott L. Utilization of online focus groups to include mothers: A use-case design, reflection, and recommendations. Digit Health. 2018;4:2055207618777675.PubMedPubMedCentral Skelton K, Evans R, LaChenaye J, Amsbary J, Wingate M, Talbott L. Utilization of online focus groups to include mothers: A use-case design, reflection, and recommendations. Digit Health. 2018;4:2055207618777675.PubMedPubMedCentral
46.
go back to reference Williams S, Clausen MG, Robertson A, Peacock S, McPherson K. Methodological Reflections on the Use of Asynchronous Online Focus Groups in Health Research. Int J Qual Methods. 2012;11:368–83.CrossRef Williams S, Clausen MG, Robertson A, Peacock S, McPherson K. Methodological Reflections on the Use of Asynchronous Online Focus Groups in Health Research. Int J Qual Methods. 2012;11:368–83.CrossRef
48.
go back to reference Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277–88.PubMedCrossRef Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277–88.PubMedCrossRef
50.
go back to reference Bashirian S, Jenabi E, Khazaei S, Barati M, Karimi-Shahanjarini A, Zareian S, et al. Factors associated with preventive behaviours of COVID-19 among hospital staff in Iran in 2020: an application of the Protection Motivation Theory. J Hosp Infect. 2020;105:430–3.PubMedPubMedCentralCrossRef Bashirian S, Jenabi E, Khazaei S, Barati M, Karimi-Shahanjarini A, Zareian S, et al. Factors associated with preventive behaviours of COVID-19 among hospital staff in Iran in 2020: an application of the Protection Motivation Theory. J Hosp Infect. 2020;105:430–3.PubMedPubMedCentralCrossRef
51.
go back to reference Schmees R. The Role of Cognitive Appraisals and Past Protective Behavior in Future Protection Motivation: Applying Protection Motivation Theory to the COVID-19 Pandemic; 2020. Schmees R. The Role of Cognitive Appraisals and Past Protective Behavior in Future Protection Motivation: Applying Protection Motivation Theory to the COVID-19 Pandemic; 2020.
52.
go back to reference Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Damme PV, et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.PubMedCrossRef Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Damme PV, et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.PubMedCrossRef
53.
go back to reference Genuis SK, Luth W, Campbell S, Bubela T, Johnston WS. Communication About End of Life for Patients Living With Amyotrophic Lateral Sclerosis: A Scoping Review of the Empirical Evidence. Front Neurol. 2021;12:1332.CrossRef Genuis SK, Luth W, Campbell S, Bubela T, Johnston WS. Communication About End of Life for Patients Living With Amyotrophic Lateral Sclerosis: A Scoping Review of the Empirical Evidence. Front Neurol. 2021;12:1332.CrossRef
54.
go back to reference Long R, Havics B, Zembillas M, Kelly J, Amundson M. Elucidating the End-of-Life Experience of Persons With Amyotrophic Lateral Sclerosis. [Review]. Holist Nurs Pract. 2019;33:3–8.PubMedCrossRef Long R, Havics B, Zembillas M, Kelly J, Amundson M. Elucidating the End-of-Life Experience of Persons With Amyotrophic Lateral Sclerosis. [Review]. Holist Nurs Pract. 2019;33:3–8.PubMedCrossRef
55.
go back to reference Murray L, Butow PN. Advance care planning in motor neuron disease: A systematic review. Palliat Support Care. 2016;14:411–32.PubMedCrossRef Murray L, Butow PN. Advance care planning in motor neuron disease: A systematic review. Palliat Support Care. 2016;14:411–32.PubMedCrossRef
56.
go back to reference Shoesmith C, Abrahao A, Benstead T, Chum M, Dupre N, Izenberg A, et al. Canadian best practice recommendations for the management of amyotrophic lateral sclerosis. CMAJ Can Med Assoc J. 2020;192:E1453–68.CrossRef Shoesmith C, Abrahao A, Benstead T, Chum M, Dupre N, Izenberg A, et al. Canadian best practice recommendations for the management of amyotrophic lateral sclerosis. CMAJ Can Med Assoc J. 2020;192:E1453–68.CrossRef
57.
go back to reference Milne S, Sheeran P, Orbell S. Prediction and Intervention in Health-Related Behavior: A Meta-Analytic Review of Protection Motivation Theory. J Appl Soc Psychol. 2000;30:106–43.CrossRef Milne S, Sheeran P, Orbell S. Prediction and Intervention in Health-Related Behavior: A Meta-Analytic Review of Protection Motivation Theory. J Appl Soc Psychol. 2000;30:106–43.CrossRef
58.
go back to reference Williams NL, Nguyen THH, Del Chiappa G, Fedeli G, Wassler P. COVID-19 vaccine confidence and tourism at the early stage of a voluntary mass vaccination campaign: a PMT segmentation analysis. Curr Issue Tour. 2021;0:1–15. Williams NL, Nguyen THH, Del Chiappa G, Fedeli G, Wassler P. COVID-19 vaccine confidence and tourism at the early stage of a voluntary mass vaccination campaign: a PMT segmentation analysis. Curr Issue Tour. 2021;0:1–15.
59.
go back to reference Kim JK, Crimmins EM. Age differences in the relationship between threatening and coping mechanisms and preventive behaviors in the time of COVID-19 in the United States: Protection Motivation Theory. Res Psychother Psychopathol Process Outcome. 2021;23:485. Kim JK, Crimmins EM. Age differences in the relationship between threatening and coping mechanisms and preventive behaviors in the time of COVID-19 in the United States: Protection Motivation Theory. Res Psychother Psychopathol Process Outcome. 2021;23:485.
60.
go back to reference Šuriņa S, Martinsone K, Perepjolkina V, Kolesnikova J, Vainik U, Ruža A, et al. Factors Related to COVID-19 Preventive Behaviors: A Structural Equation Model. Front Psychol. 2021;12:676521.PubMedPubMedCentralCrossRef Šuriņa S, Martinsone K, Perepjolkina V, Kolesnikova J, Vainik U, Ruža A, et al. Factors Related to COVID-19 Preventive Behaviors: A Structural Equation Model. Front Psychol. 2021;12:676521.PubMedPubMedCentralCrossRef
61.
go back to reference Brott T, Hocking C, Paddy A. Occupational Disruption: Living with Motor Neurone Disease. Br J Occup Ther. 2007;70:24–31.CrossRef Brott T, Hocking C, Paddy A. Occupational Disruption: Living with Motor Neurone Disease. Br J Occup Ther. 2007;70:24–31.CrossRef
62.
go back to reference Brown J, Addington-Hall J. How people with motor neurone disease talk about living with their illness: a narrative study. J Adv Nurs. 2008;62:200–8.PubMedCrossRef Brown J, Addington-Hall J. How people with motor neurone disease talk about living with their illness: a narrative study. J Adv Nurs. 2008;62:200–8.PubMedCrossRef
63.
go back to reference Harris DA. Lived-through past, experienced present, anticipated future: Understanding “existential loss” in the context of life-limiting illness. Palliat Support Care. 2015;13:1579–94.PubMedCrossRef Harris DA. Lived-through past, experienced present, anticipated future: Understanding “existential loss” in the context of life-limiting illness. Palliat Support Care. 2015;13:1579–94.PubMedCrossRef
64.
go back to reference Ozanne A, Graneheim UH. Understanding the incomprehensible – patients’ and spouses’ experiences of comprehensibility before, at and after diagnosis of amyotrophic lateral sclerosis. Scand J Caring Sci. 2018;32:663–71.PubMedCrossRef Ozanne A, Graneheim UH. Understanding the incomprehensible – patients’ and spouses’ experiences of comprehensibility before, at and after diagnosis of amyotrophic lateral sclerosis. Scand J Caring Sci. 2018;32:663–71.PubMedCrossRef
65.
go back to reference Aoun SM, Breen LJ, Howting D, Edis R, Oliver D, Henderson R, et al. Receiving the news of a diagnosis of motor neuron disease: What does it take to make it better? Amyotroph Lateral Scler Front Degener. 2016;17:168–78.CrossRef Aoun SM, Breen LJ, Howting D, Edis R, Oliver D, Henderson R, et al. Receiving the news of a diagnosis of motor neuron disease: What does it take to make it better? Amyotroph Lateral Scler Front Degener. 2016;17:168–78.CrossRef
66.
go back to reference O’Brien MR, Whitehead B, Jack BA, Mitchell JD. From symptom onset to a diagnosis of amyotrophic lateral sclerosis/motor neuron disease (ALS/MND): Experiences of people with ALS/MND and family carers – a qualitative study. Amyotroph Lateral Scler. 2011;12:97–104.PubMedCrossRef O’Brien MR, Whitehead B, Jack BA, Mitchell JD. From symptom onset to a diagnosis of amyotrophic lateral sclerosis/motor neuron disease (ALS/MND): Experiences of people with ALS/MND and family carers – a qualitative study. Amyotroph Lateral Scler. 2011;12:97–104.PubMedCrossRef
67.
go back to reference Peters M, Fitzpatrick R, Doll H, Playford ED, Jenkinson C. Patients’ experiences of health and social care in long-term neurological conditions in England: a cross-sectional survey. J Health Serv Res Policy. 2013;18:28–33.PubMedCrossRef Peters M, Fitzpatrick R, Doll H, Playford ED, Jenkinson C. Patients’ experiences of health and social care in long-term neurological conditions in England: a cross-sectional survey. J Health Serv Res Policy. 2013;18:28–33.PubMedCrossRef
68.
go back to reference van Eenennaam RM, Kruithof WJ, van Es MA, Kruitwagen-van Reenen ET, Westeneng H-J, Visser-Meily JMA, et al. Discussing personalized prognosis in amyotrophic lateral sclerosis: development of a communication guide. BMC Neurol. 2020;20:446.PubMedPubMedCentralCrossRef van Eenennaam RM, Kruithof WJ, van Es MA, Kruitwagen-van Reenen ET, Westeneng H-J, Visser-Meily JMA, et al. Discussing personalized prognosis in amyotrophic lateral sclerosis: development of a communication guide. BMC Neurol. 2020;20:446.PubMedPubMedCentralCrossRef
69.
go back to reference Abdulla S, Vielhaber S, Kollewe K, Machts J, Heinze H-J, Dengler R, et al. The impact of physical impairment on emotional well-being in ALS. Amyotroph Lateral Scler Front Degener. 2014;15:392–7.CrossRef Abdulla S, Vielhaber S, Kollewe K, Machts J, Heinze H-J, Dengler R, et al. The impact of physical impairment on emotional well-being in ALS. Amyotroph Lateral Scler Front Degener. 2014;15:392–7.CrossRef
70.
go back to reference Chiò A, Montuschi A, Cammarosano S, Mercanti SD, Cavallo E, Ilardi A, et al. ALS patients and caregivers communication preferences and information seeking behaviour. Eur J Neurol. 2008;15:55–60.PubMedCrossRef Chiò A, Montuschi A, Cammarosano S, Mercanti SD, Cavallo E, Ilardi A, et al. ALS patients and caregivers communication preferences and information seeking behaviour. Eur J Neurol. 2008;15:55–60.PubMedCrossRef
71.
go back to reference Hogden A, Greenfield D, Nugus P, Kiernan MC. Engaging in patient decision-making in multidisciplinary care for amyotrophic lateral sclerosis: the views of health professionals. Patient Prefer Adher. 2012;6:691–701.CrossRef Hogden A, Greenfield D, Nugus P, Kiernan MC. Engaging in patient decision-making in multidisciplinary care for amyotrophic lateral sclerosis: the views of health professionals. Patient Prefer Adher. 2012;6:691–701.CrossRef
72.
go back to reference Oh J, Kim JA. Information-seeking Behavior and Information Needs in Patients With Amyotrophic Lateral Sclerosis: Analyzing an Online Patient Community. CIN Comput Inform Nurs. 2017;35:345–51.PubMed Oh J, Kim JA. Information-seeking Behavior and Information Needs in Patients With Amyotrophic Lateral Sclerosis: Analyzing an Online Patient Community. CIN Comput Inform Nurs. 2017;35:345–51.PubMed
73.
74.
go back to reference Tangcharoensathien V, Calleja N, Nguyen T, Purnat T, D’Agostino M, Garcia-Saiso S, et al. Framework for Managing the COVID-19 Infodemic: Methods and Results of an Online, Crowdsourced WHO Technical Consultation. J Med Internet Res. 2020;22:e19659.PubMedPubMedCentralCrossRef Tangcharoensathien V, Calleja N, Nguyen T, Purnat T, D’Agostino M, Garcia-Saiso S, et al. Framework for Managing the COVID-19 Infodemic: Methods and Results of an Online, Crowdsourced WHO Technical Consultation. J Med Internet Res. 2020;22:e19659.PubMedPubMedCentralCrossRef
75.
go back to reference Vraga EK, Bode L. Addressing COVID-19 Misinformation on Social Media Preemptively and Responsively - Volume 27, Number 2—February 2021 - Emerging Infectious Diseases journal - CDC. Emerg Enfectious Dis. 2021;27:396–403.CrossRef Vraga EK, Bode L. Addressing COVID-19 Misinformation on Social Media Preemptively and Responsively - Volume 27, Number 2—February 2021 - Emerging Infectious Diseases journal - CDC. Emerg Enfectious Dis. 2021;27:396–403.CrossRef
76.
77.
go back to reference Finset A, Bosworth H, Butow P, Gulbrandsen P, Hulsman RL, Pieterse AH, et al. Effective health communication – a key factor in fighting the COVID-19 pandemic. Patient Educ Couns. 2020;103:873–6.PubMedPubMedCentralCrossRef Finset A, Bosworth H, Butow P, Gulbrandsen P, Hulsman RL, Pieterse AH, et al. Effective health communication – a key factor in fighting the COVID-19 pandemic. Patient Educ Couns. 2020;103:873–6.PubMedPubMedCentralCrossRef
78.
go back to reference Sonekar HB, Ponnaiah M. Emergence of Coronavirus (COVID-19) Outbreak: Anthropological and Social Science Perspectives. Disaster Med Public Health Prep. 2020;14:759–61.PubMedCrossRef Sonekar HB, Ponnaiah M. Emergence of Coronavirus (COVID-19) Outbreak: Anthropological and Social Science Perspectives. Disaster Med Public Health Prep. 2020;14:759–61.PubMedCrossRef
79.
go back to reference Lancet T. COVID-19: fighting panic with information. Lancet Lond Engl. 2020;395:537.CrossRef Lancet T. COVID-19: fighting panic with information. Lancet Lond Engl. 2020;395:537.CrossRef
80.
go back to reference Zullo S, Ingravallo F, Crespi V, Cascioli M, D’Alessandro R, Gasperini M, et al. The impact of the COVID-19 pandemic on people with neurological disorders: an urgent need to enhance the health care system’s preparedness. Neurol Sci. 2021;42:799–804.PubMedPubMedCentralCrossRef Zullo S, Ingravallo F, Crespi V, Cascioli M, D’Alessandro R, Gasperini M, et al. The impact of the COVID-19 pandemic on people with neurological disorders: an urgent need to enhance the health care system’s preparedness. Neurol Sci. 2021;42:799–804.PubMedPubMedCentralCrossRef
84.
go back to reference D’Alvano G, Buonanno D, Passaniti C, De Stefano M, Lavorgna L, Tedeschi G, et al. Support Needs and Interventions for Family Caregivers of Patients with Amyotrophic Lateral Sclerosis (ALS): A Narrative Review with Report of Telemedicine Experiences at the Time of COVID-19 Pandemic. Brain Sci. 2022;12:49.CrossRef D’Alvano G, Buonanno D, Passaniti C, De Stefano M, Lavorgna L, Tedeschi G, et al. Support Needs and Interventions for Family Caregivers of Patients with Amyotrophic Lateral Sclerosis (ALS): A Narrative Review with Report of Telemedicine Experiences at the Time of COVID-19 Pandemic. Brain Sci. 2022;12:49.CrossRef
86.
go back to reference Tomik B, Professor RJG. Dysarthria in amyotrophic lateral sclerosis: A review. Amyotroph Lateral Scler. 2010;11:4–15.PubMedCrossRef Tomik B, Professor RJG. Dysarthria in amyotrophic lateral sclerosis: A review. Amyotroph Lateral Scler. 2010;11:4–15.PubMedCrossRef
87.
go back to reference Munan M, Luth W, Genuis SK, Johnston WS, MacIntyre E. Transitions in amyotrophic lateral sclerosis: patient and caregiver experiences. Can J Neurol Sci. 2021;48(4):496–503. Munan M, Luth W, Genuis SK, Johnston WS, MacIntyre E. Transitions in amyotrophic lateral sclerosis: patient and caregiver experiences. Can J Neurol Sci. 2021;48(4):496–503.
88.
go back to reference Epstein S, Campanile J, Cerilli C, Gajwani P, Varadaraj V, Swenor BK. New obstacles and widening gaps: A qualitative study of the effects of the COVID-19 pandemic on U.S. adults with disabilities. Disabil Health J. 2021;14:101103.PubMedCrossRef Epstein S, Campanile J, Cerilli C, Gajwani P, Varadaraj V, Swenor BK. New obstacles and widening gaps: A qualitative study of the effects of the COVID-19 pandemic on U.S. adults with disabilities. Disabil Health J. 2021;14:101103.PubMedCrossRef
89.
go back to reference Stough LM, Kang D. The Sendai Framework for Disaster Risk Reduction and Persons with Disabilities. Int J Disaster Risk Sci. 2015;6:140–9.CrossRef Stough LM, Kang D. The Sendai Framework for Disaster Risk Reduction and Persons with Disabilities. Int J Disaster Risk Sci. 2015;6:140–9.CrossRef
90.
go back to reference United Nations Office for Disaster Risk Reduction. Sendai Framework for Disaster Risk Reduction 2015–2030. Geneva: United Nations; 2015. United Nations Office for Disaster Risk Reduction. Sendai Framework for Disaster Risk Reduction 2015–2030. Geneva: United Nations; 2015.
91.
go back to reference Pyke C, Wilton R. Planning for inclusion? An assessment of Ontario’s emergency preparedness guide for people with disabilities. Int J Disaster Risk Reduct. 2020;51:101888.CrossRef Pyke C, Wilton R. Planning for inclusion? An assessment of Ontario’s emergency preparedness guide for people with disabilities. Int J Disaster Risk Reduct. 2020;51:101888.CrossRef
92.
go back to reference Quaill J, Barker RN, West C. Experiences of people with physical disabilities before, during, and after tropical cyclones in Queensland, Australia. Int J Disaster Risk Reduct. 2019;39:101122.CrossRef Quaill J, Barker RN, West C. Experiences of people with physical disabilities before, during, and after tropical cyclones in Queensland, Australia. Int J Disaster Risk Reduct. 2019;39:101122.CrossRef
93.
go back to reference Tanaka Y, Hotta M, Inuzuka T. The preparations of patients with amyotrophic lateral sclerosis for disaster after the Great East Japan earthquake. J Neurol Sci. 2017;379:304–5.PubMedCrossRef Tanaka Y, Hotta M, Inuzuka T. The preparations of patients with amyotrophic lateral sclerosis for disaster after the Great East Japan earthquake. J Neurol Sci. 2017;379:304–5.PubMedCrossRef
95.
go back to reference Boyle CA, Fox MH, Havercamp SM, Zubler J. The public health response to the COVID-19 pandemic for people with disabilities. Disabil Health J. 2020;13:100943.PubMedPubMedCentralCrossRef Boyle CA, Fox MH, Havercamp SM, Zubler J. The public health response to the COVID-19 pandemic for people with disabilities. Disabil Health J. 2020;13:100943.PubMedPubMedCentralCrossRef
96.
go back to reference Schwartz AE, Munsell EGS, Schmidt EK, Colón-Semenza C, Carolan K, Gassner DL. Impact of COVID-19 on services for people with disabilities and chronic health conditions. Disabil Health J. 2021;14:101090.PubMedCrossRef Schwartz AE, Munsell EGS, Schmidt EK, Colón-Semenza C, Carolan K, Gassner DL. Impact of COVID-19 on services for people with disabilities and chronic health conditions. Disabil Health J. 2021;14:101090.PubMedCrossRef
97.
go back to reference Bennett D. Five Years Later: Assessing the Implementation of the Four Priorities of the Sendai Framework for Inclusion of People with Disabilities. Int J Disaster Risk Sci. 2020;11:155–66.CrossRef Bennett D. Five Years Later: Assessing the Implementation of the Four Priorities of the Sendai Framework for Inclusion of People with Disabilities. Int J Disaster Risk Sci. 2020;11:155–66.CrossRef
98.
go back to reference Pickering CJ, Dancey M, Paik K, O’Sullivan T. Informal Caregiving and Disaster Risk Reduction: A Scoping Review. Int J Disaster Risk Sci. 2021;12:169–87.CrossRef Pickering CJ, Dancey M, Paik K, O’Sullivan T. Informal Caregiving and Disaster Risk Reduction: A Scoping Review. Int J Disaster Risk Sci. 2021;12:169–87.CrossRef
99.
go back to reference Subramaniam P, Villeneuve M. Advancing emergency preparedness for people with disabilities and chronic health conditions in the community: a scoping review. Disabil Rehabil. 2020;42:3256–64.PubMedCrossRef Subramaniam P, Villeneuve M. Advancing emergency preparedness for people with disabilities and chronic health conditions in the community: a scoping review. Disabil Rehabil. 2020;42:3256–64.PubMedCrossRef
101.
go back to reference Anderson NH, Gluyas C, Mathers S, Hudson P, Ugalde A. “A monster that lives in our lives”: experiences of caregivers of people with motor neuron disease and identifying avenues for support. BMJ Support Palliat Care. 2019;9:e27.PubMed Anderson NH, Gluyas C, Mathers S, Hudson P, Ugalde A. “A monster that lives in our lives”: experiences of caregivers of people with motor neuron disease and identifying avenues for support. BMJ Support Palliat Care. 2019;9:e27.PubMed
102.
go back to reference de Wit J, Beelen A, Drossaert CHC, Kolijn R, van den Berg LH, Visser-Meily JMA, et al. A blended psychosocial support program for partners of patients with amyotrophic lateral sclerosis and progressive muscular atrophy: protocol of a randomized controlled trial. BMC Psychol. 2018;6:20.PubMedPubMedCentralCrossRef de Wit J, Beelen A, Drossaert CHC, Kolijn R, van den Berg LH, Visser-Meily JMA, et al. A blended psychosocial support program for partners of patients with amyotrophic lateral sclerosis and progressive muscular atrophy: protocol of a randomized controlled trial. BMC Psychol. 2018;6:20.PubMedPubMedCentralCrossRef
104.
go back to reference European Centre for Disease Prevention and Control. Considerations relating to social distancing measures in response to COVID-19 – second update. Stockholm: ECDC; 2020. European Centre for Disease Prevention and Control. Considerations relating to social distancing measures in response to COVID-19 – second update. Stockholm: ECDC; 2020.
105.
go back to reference King J, Edwards N, Watling H, Hair S. Barriers to disability-inclusive disaster management in the Solomon Islands: Perspectives of people with disability. Int J Disaster Risk Reduct. 2019;34:459–66.CrossRef King J, Edwards N, Watling H, Hair S. Barriers to disability-inclusive disaster management in the Solomon Islands: Perspectives of people with disability. Int J Disaster Risk Reduct. 2019;34:459–66.CrossRef
107.
go back to reference Marshall C, Rossman GB. Designing qualitative research. 4th ed. Thousand Oaks: Sage Publications, Inc; 2006. Marshall C, Rossman GB. Designing qualitative research. 4th ed. Thousand Oaks: Sage Publications, Inc; 2006.
Metadata
Title
Covid-19 threat and coping: application of protection motivation theory to the pandemic experiences of people affected by amyotrophic lateral sclerosis
Authors
Shelagh K. Genuis
Westerly Luth
Tania Bubela
Wendy S. Johnston
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-022-02662-w

Other articles of this Issue 1/2022

BMC Neurology 1/2022 Go to the issue